{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:02:45Z","timestamp":1788447765202,"version":"build-2803163510"},"reference-count":116,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,2,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Respiratory syncytial virus (RSV) infection can cause severe disease in the lower respiratory tract of infants and older people. Vaccination with a formalin-inactivated RSV vaccine (FI-RSV) and subsequent RSV infection has led to mild to severe pneumonia with two deaths among vaccinees. The vaccine-enhanced disease (VED) was recently demonstrated to be due to an elevated level of Th2 cell responses following loss of regulatory T (Treg) cells from the lungs. To induce high levels of neutralizing Abs and minimize pathogenic T cell responses, we developed a novel strategy of immunizing animals with a recombinant RSV G protein together with cyclosporine A. This novel vaccine induced not only a higher level of neutralizing Abs against RSV infection, but, most importantly, also significantly higher levels of Treg cells that suppressed VED in the lung after RSV infection. The induced responses provided protection against RSV challenge with no sign of pneumonia or bronchitis. Treg cell production of IL-10 was one of the key factors to suppress VED. These finding indicate that G protein plus cyclosporine A could be a promising vaccine against RSV infection in children and older people.<\/jats:p>","DOI":"10.4049\/jimmunol.1502103","type":"journal-article","created":{"date-parts":[[2016,1,21]],"date-time":"2016-01-21T03:14:35Z","timestamp":1453346075000},"page":"1721-1731","source":"Crossref","is-referenced-by-count":38,"title":["A Recombinant G Protein Plus Cyclosporine A\u2013Based Respiratory Syncytial Virus Vaccine Elicits Humoral and Regulatory T Cell Responses against Infection without Vaccine-Enhanced Disease"],"prefix":"10.1093","volume":"196","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5426-1498","authenticated-orcid":false,"given":"Chaofan","family":"Li","sequence":"first","affiliation":[{"name":"Key Laboratory of Medical Molecular Virology of the Ministry of Health and the Ministry of Education, Shanghai Medical College, Fudan University , Shanghai 201508 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Zhou","sequence":"additional","affiliation":[{"name":"Key Laboratory of Medical Molecular Virology of the Ministry of Health and the Ministry of Education, Shanghai Medical College, Fudan University , Shanghai 201508 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwei","family":"Zhong","sequence":"additional","affiliation":[{"name":"Key Laboratory of Medical Molecular Virology of the Ministry of Health and the Ministry of Education, Shanghai Medical College, Fudan University , Shanghai 201508 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changgui","family":"Li","sequence":"additional","affiliation":[{"name":"Division for Respiratory Viral Vaccines of National Institutes for Food and Drug Control , Beijing 100050 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aihua","family":"Dong","sequence":"additional","affiliation":[{"name":"Beijing Advaccine Biotechnology Company, Ltd. , Beijing 100085 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonghuai","family":"He","sequence":"additional","affiliation":[{"name":"Beijing Advaccine Biotechnology Company, Ltd. , Beijing 100085 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuren","family":"Zhang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Medical Molecular Virology of the Ministry of Health and the Ministry of Education, Shanghai Medical College, Fudan University , Shanghai 201508 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Medical Molecular Virology of the Ministry of Health and the Ministry of Education, Shanghai Medical College, Fudan University , Shanghai 201508 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,2,15]]},"reference":[{"key":"2025030702134073700_r1","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jcrc.2011.12.001","article-title":"Respiratory syncytial virus morbidity, premorbid factors, seasonality, and implications for prophylaxis","volume":"27","author":"Hon","year":"2012","journal-title":"J. Crit. Care"},{"key":"2025030702134073700_r2","doi-asserted-by":"crossref","first-page":"e1453","DOI":"10.1542\/peds.2010-0507","article-title":"Risk factors in children hospitalized with RSV bronchiolitis versus non-RSV bronchiolitis","volume":"126","author":"Garc\u00eda","year":"2010","journal-title":"Pediatrics"},{"key":"2025030702134073700_r3","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.virusres.2011.09.020","article-title":"Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years","volume":"162","author":"Collins","year":"2011","journal-title":"Virus Res."},{"key":"2025030702134073700_r4","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(10)60206-1","article-title":"Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis","volume":"375","author":"Nair","year":"2010","journal-title":"Lancet"},{"key":"2025030702134073700_r5","first-page":"397","article-title":"Respiratory syncytial virus: clinical and epidemiological pattern in pediatric patients admitted to a children\u2019s hospital between 2000 and 2013","volume":"112","author":"Lucion","year":"2014","journal-title":"Arch. Argent. Pediatr."},{"key":"2025030702134073700_r6","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1185\/03007995.2010.505126","article-title":"Fatality rates in published reports of RSV hospitalizations among high-risk and otherwise healthy children","volume":"26","author":"Welliver","year":"2010","journal-title":"Curr. Med. Res. Opin."},{"key":"2025030702134073700_r7","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1038\/nm.2896","article-title":"Early infection with respiratory syncytial virus impairs regulatory T cell function and increases susceptibility to allergic asthma","volume":"18","author":"Krishnamoorthy","year":"2012","journal-title":"Nat. Med."},{"key":"2025030702134073700_r8","doi-asserted-by":"crossref","first-page":"12424","DOI":"10.1128\/JVI.00806-09","article-title":"Cell cycle arrest by transforming growth factor \u03b21 enhances replication of respiratory syncytial virus in lung epithelial cells","volume":"83","author":"Gibbs","year":"2009","journal-title":"J. Virol."},{"key":"2025030702134073700_r9","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1099\/vir.0.19769-0","article-title":"The small hydrophobic (SH) protein accumulates within lipid-raft structures of the Golgi complex during respiratory syncytial virus infection","volume":"85","author":"Rixon","year":"2004","journal-title":"J. Gen. Virol."},{"key":"2025030702134073700_r10","doi-asserted-by":"crossref","first-page":"e1001336","DOI":"10.1371\/journal.ppat.1001336","article-title":"Respiratory syncytial virus interferon antagonist NS1 protein suppresses and skews the human T lymphocyte response","volume":"7","author":"Munir","year":"2011","journal-title":"PLoS Pathog."},{"key":"2025030702134073700_r11","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1128\/JVI.01420-06","article-title":"Nonstructural proteins of respiratory syncytial virus suppress premature apoptosis by an NF-\u03baB-dependent, interferon-independent mechanism and facilitate virus growth","volume":"81","author":"Bitko","year":"2007","journal-title":"J. Virol."},{"key":"2025030702134073700_r12","doi-asserted-by":"crossref","first-page":"8780","DOI":"10.1128\/JVI.00630-08","article-title":"Nonstructural proteins 1 and 2 of respiratory syncytial virus suppress maturation of human dendritic cells","volume":"82","author":"Munir","year":"2008","journal-title":"J. Virol."},{"key":"2025030702134073700_r13","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/oxfordjournals.aje.a120954","article-title":"An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine","volume":"89","author":"Kapikian","year":"1969","journal-title":"Am. J. Epidemiol."},{"key":"2025030702134073700_r14","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/oxfordjournals.aje.a120955","article-title":"Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine","volume":"89","author":"Kim","year":"1969","journal-title":"Am. J. Epidemiol."},{"key":"2025030702134073700_r15","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1365-2249.2005.02780.x","article-title":"Respiratory syncytial virus and neutrophil activation","volume":"140","author":"Bataki","year":"2005","journal-title":"Clin. Exp. Immunol."},{"key":"2025030702134073700_r16","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2249.2006.03084.x","article-title":"Systemic eosinophil response induced by respiratory syncytial virus","volume":"144","author":"Lindemans","year":"2006","journal-title":"Clin. Exp. Immunol."},{"key":"2025030702134073700_r17","doi-asserted-by":"crossref","first-page":"10070","DOI":"10.1128\/JVI.01347-13","article-title":"The respiratory syncytial virus fusion protein and neutrophils mediate the airway mucin response to pathogenic respiratory syncytial virus infection","volume":"87","author":"Stokes","year":"2013","journal-title":"J. Virol."},{"key":"2025030702134073700_r18","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1084\/jem.168.3.1163","article-title":"Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus","volume":"168","author":"Cannon","year":"1988","journal-title":"J. Exp. Med."},{"key":"2025030702134073700_r19","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1172\/JCI115362","article-title":"Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice","volume":"88","author":"Graham","year":"1991","journal-title":"J. Clin. Invest."},{"key":"2025030702134073700_r20","doi-asserted-by":"crossref","first-page":"5321","DOI":"10.1128\/jvi.68.8.5321-5325.1994","article-title":"Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB\/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10","volume":"68","author":"Connors","year":"1994","journal-title":"J. Virol."},{"key":"2025030702134073700_r21","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/infdis\/172.3.734","article-title":"Interleukin-12 treatment during immunization elicits a T helper cell type 1-like immune response in mice challenged with respiratory syncytial virus and improves vaccine immunogenicity","volume":"172","author":"Tang","year":"1995","journal-title":"J. Infect. Dis."},{"key":"2025030702134073700_r22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/rmv.518","article-title":"Immunopathology of RSV infection: prospects for developing vaccines without this complication","volume":"17","author":"van Drunen Littel-van den Hurk","year":"2007","journal-title":"Rev. Med. Virol."},{"key":"2025030702134073700_r23","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1084\/jem.20020781","article-title":"A role for immune complexes in enhanced respiratory syncytial virus disease","volume":"196","author":"Polack","year":"2002","journal-title":"J. Exp. Med."},{"key":"2025030702134073700_r24","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1128\/CMR.18.3.541-555.2005","article-title":"Immune responses and disease enhancement during respiratory syncytial virus infection","volume":"18","author":"Openshaw","year":"2005","journal-title":"Clin. Microbiol. Rev."},{"key":"2025030702134073700_r25","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s12026-007-0071-6","article-title":"Understanding respiratory syncytial virus (RSV) vaccine-enhanced disease","volume":"39","author":"Castilow","year":"2007","journal-title":"Immunol. Res."},{"key":"2025030702134073700_r26","doi-asserted-by":"crossref","first-page":"8753","DOI":"10.1128\/JVI.78.16.8753-8760.2004","article-title":"V\u03b214+ T cells mediate the vaccine-enhanced disease induced by immunization with respiratory syncytial virus (RSV) G glycoprotein but not with formalin-inactivated RSV","volume":"78","author":"Johnson","year":"2004","journal-title":"J. Virol."},{"key":"2025030702134073700_r27","doi-asserted-by":"crossref","first-page":"12421","DOI":"10.1128\/JVI.75.24.12421-12430.2001","article-title":"Differential histopathology and chemokine gene expression in lung tissues following respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV- or BBG2Na-immunized mice","volume":"75","author":"Power","year":"2001","journal-title":"J. Virol."},{"key":"2025030702134073700_r28","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.4049\/jimmunol.151.4.2032","article-title":"Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus","volume":"151","author":"Graham","year":"1993","journal-title":"J. Immunol."},{"key":"2025030702134073700_r29","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/icb.2009.115","article-title":"Eosinophils and Th2 immunity: contemporary insights","volume":"88","author":"Spencer","year":"2010","journal-title":"Immunol. Cell Biol."},{"key":"2025030702134073700_r30","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1186\/1743-422X-8-375","article-title":"Absence of vaccine-enhanced RSV disease and changes in pulmonary dendritic cells with adenovirus-based RSV vaccine","volume":"8","author":"Krause","year":"2011","journal-title":"Virol. J."},{"key":"2025030702134073700_r31","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/INF.0000000000000240","article-title":"Motavizumab treatment of infants hospitalized with respiratory syncytial virus infection does not decrease viral load or severity of illness","volume":"33","author":"Ramilo","year":"2014","journal-title":"Pediatr. Infect. Dis. J."},{"key":"2025030702134073700_r32","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1542\/peds.102.5.1211","article-title":"Prevention of respiratory syncytial virus infections: indications for the use of palivizumab and update on the use of RSV-IGIV","volume":"102","author":"Halsey","year":"1998","journal-title":"Pediatrics"},{"key":"2025030702134073700_r33","doi-asserted-by":"crossref","first-page":"10946","DOI":"10.1128\/JVI.01295-13","article-title":"Regulatory T cells prevent Th2 immune responses and pulmonary eosinophilia during respiratory syncytial virus infection in mice","volume":"87","author":"Durant","year":"2013","journal-title":"J. Virol."},{"key":"2025030702134073700_r34","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nri2785","article-title":"FOXP3+ regulatory T cells in the human immune system","volume":"10","author":"Sakaguchi","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"2025030702134073700_r35","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0896-8411(03)00045-3","article-title":"Interleukin-10 in the regulation of T cell-induced colitis","volume":"20","author":"Annacker","year":"2003","journal-title":"J. Autoimmun."},{"key":"2025030702134073700_r36","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.4049\/jimmunol.178.2.1039","article-title":"Coordinated control of immunity to muscle stage Trichinella spiralis by IL-10, regulatory T cells, and TGF-\u03b2","volume":"178","author":"Beiting","year":"2007","journal-title":"J. Immunol."},{"key":"2025030702134073700_r37","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1002\/eji.200425274","article-title":"Interleukin-2 is essential for CD4+CD25+ regulatory T cell function","volume":"34","author":"de la Rosa","year":"2004","journal-title":"Eur. J. Immunol."},{"key":"2025030702134073700_r38","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1084\/jem.192.2.295","article-title":"Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25+CD4+ regulatory cells that control intestinal inflammation","volume":"192","author":"Read","year":"2000","journal-title":"J. Exp. Med."},{"key":"2025030702134073700_r39","doi-asserted-by":"crossref","first-page":"6426","DOI":"10.4049\/jimmunol.0903940","article-title":"Cutting edge: mechanisms of IL-2-dependent maintenance of functional regulatory T cells","volume":"185","author":"Barron","year":"2010","journal-title":"J. Immunol."},{"key":"2025030702134073700_r40","doi-asserted-by":"crossref","first-page":"5360","DOI":"10.4049\/jimmunol.180.8.5360","article-title":"Induction of adaptive T regulatory cells that suppress the allergic response by coimmunization of DNA and protein vaccines","volume":"180","author":"Jin","year":"2008","journal-title":"J. Immunol."},{"key":"2025030702134073700_r41","doi-asserted-by":"crossref","first-page":"e49994","DOI":"10.1371\/journal.pone.0049994","article-title":"Treg cell resistance to apoptosis in DNA vaccination for experimental autoimmune encephalomyelitis treatment","volume":"7","author":"Kang","year":"2012","journal-title":"PLoS One"},{"key":"2025030702134073700_r42","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/imr.12085","article-title":"Role of regulatory T cells during virus infection","volume":"255","author":"Veiga-Parga","year":"2013","journal-title":"Immunol. Rev."},{"key":"2025030702134073700_r43","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1084\/jem.20070081","article-title":"Altering the distribution of Foxp3+ regulatory T cells results in tissue-specific inflammatory disease","volume":"204","author":"Sather","year":"2007","journal-title":"J. Exp. Med."},{"key":"2025030702134073700_r44","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/nri3605","article-title":"Homeostatic control of regulatory T cell diversity","volume":"14","author":"Liston","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"2025030702134073700_r45","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1073\/pnas.1217580110","article-title":"Defective immunoregulation in RSV vaccine-augmented viral lung disease restored by selective chemoattraction of regulatory T cells","volume":"110","author":"Loebbermann","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025030702134073700_r46","doi-asserted-by":"crossref","first-page":"8790","DOI":"10.1128\/JVI.00796-10","article-title":"CD25+ natural regulatory T cells are critical in limiting innate and adaptive immunity and resolving disease following respiratory syncytial virus infection","volume":"84","author":"Lee","year":"2010","journal-title":"J. Virol."},{"key":"2025030702134073700_r47","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1128\/jvi.65.3.1634-1637.1991","article-title":"Respiratory syncytial virus (RSV) F, G, M2 (22K), and N proteins each induce resistance to RSV challenge, but resistance induced by M2 and N proteins is relatively short-lived","volume":"65","author":"Connors","year":"1991","journal-title":"J. Virol."},{"key":"2025030702134073700_r48","doi-asserted-by":"crossref","first-page":"e34331","DOI":"10.1371\/journal.pone.0034331","article-title":"The respiratory syncytial virus G protein conserved domain induces a persistent and protective antibody response in rodents","volume":"7","author":"Nguyen","year":"2012","journal-title":"PLoS One"},{"key":"2025030702134073700_r49","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.1128\/jvi.61.12.3855-3861.1987","article-title":"Immune and histopathological responses in animals vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus","volume":"61","author":"Stott","year":"1987","journal-title":"J. Virol."},{"key":"2025030702134073700_r50","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1073\/pnas.1115941109","article-title":"Neutralizing antibodies against the preactive form of respiratory syncytial virus fusion protein offer unique possibilities for clinical intervention","volume":"109","author":"Magro","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025030702134073700_r51","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1126\/science.1234914","article-title":"Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody","volume":"340","author":"McLellan","year":"2013","journal-title":"Science"},{"key":"2025030702134073700_r52","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/90675","article-title":"CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein","volume":"2","author":"Tripp","year":"2001","journal-title":"Nat. Immunol."},{"key":"2025030702134073700_r53","doi-asserted-by":"crossref","first-page":"13466","DOI":"10.1128\/JVI.01741-13","article-title":"Respiratory syncytial virus G protein CX3C motif impairs human airway epithelial and immune cell responses","volume":"87","author":"Chirkova","year":"2013","journal-title":"J. Virol."},{"key":"2025030702134073700_r54","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.4049\/jimmunol.176.3.1600","article-title":"Respiratory syncytial virus G protein and G protein CX3C motif adversely affect CX3CR1+ T cell responses","volume":"176","author":"Harcourt","year":"2006","journal-title":"J. Immunol."},{"key":"2025030702134073700_r55","doi-asserted-by":"crossref","first-page":"7633","DOI":"10.4049\/jimmunol.0903452","article-title":"Efficient lung recruitment of respiratory syncytial virus-specific Th1 cells induced by recombinant bacillus Calmette-Gu\u00e9rin promotes virus clearance and protects from infection","volume":"185","author":"Cautivo","year":"2010","journal-title":"J. Immunol."},{"key":"2025030702134073700_r56","first-page":"193","article-title":"Antibodies to the central conserved region of respiratory syncytial virus (RSV) G protein block RSV G protein CX3C-CX3CR1 binding and cross-neutralize RSV A and B strains","volume":"25","author":"Choi","year":"2012","journal-title":"Viral Immunol."},{"key":"2025030702134073700_r57","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1086\/600108","article-title":"Therapeutic monoclonal antibody treatment targeting respiratory syncytial virus (RSV) G protein mediates viral clearance and reduces the pathogenesis of RSV infection in BALB\/c mice","volume":"200","author":"Haynes","year":"2009","journal-title":"J. Infect. Dis."},{"key":"2025030702134073700_r58","doi-asserted-by":"crossref","first-page":"e74905","DOI":"10.1371\/journal.pone.0074905","article-title":"Nanoparticle vaccines encompassing the respiratory syncytial virus (RSV) G protein CX3C chemokine motif induce robust immunity protecting from challenge and disease","volume":"8","author":"Jorquera","year":"2013","journal-title":"PLoS One"},{"key":"2025030702134073700_r59","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1006\/viro.2000.0186","article-title":"Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate","volume":"269","author":"Li","year":"2000","journal-title":"Virology"},{"key":"2025030702134073700_r60","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1086\/425516","article-title":"Anti-G protein antibody responses to respiratory syncytial virus infection or vaccination are associated with inhibition of G protein CX3C-CX3CR1 binding and leukocyte chemotaxis","volume":"190","author":"Harcourt","year":"2004","journal-title":"J. Infect. Dis."},{"key":"2025030702134073700_r61","doi-asserted-by":"crossref","first-page":"57","DOI":"10.5500\/wjt.v4.i2.57","article-title":"Calcineurin inhibitor sparing strategies in renal transplantation, part one: late sparing strategies","volume":"4","author":"Mathis","year":"2014","journal-title":"World J. Transplant."},{"key":"2025030702134073700_r62","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.jhep.2014.07.008","article-title":"Cyclophilin inhibition as potential therapy for liver diseases","volume":"61","author":"Naoumov","year":"2014","journal-title":"J. Hepatol."},{"key":"2025030702134073700_r63","first-page":"1039","article-title":"Immunosuppression in lung transplantation","volume":"6","author":"Scheffert","year":"2014","journal-title":"J. Thorac. Dis."},{"key":"2025030702134073700_r64","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1056\/NEJM199105093241901","article-title":"Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine","volume":"324","author":"Frickhofen","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"2025030702134073700_r65","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1182\/blood.V84.12.4257.bloodjournal84124257","article-title":"Identification of a specific HLA class II haplotype strongly associated with susceptibility to cyclosporine-dependent aplastic anemia","volume":"84","author":"Nakao","year":"1994","journal-title":"Blood"},{"key":"2025030702134073700_r66","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4137\/OED.S16067","article-title":"Safety and efficacy of cyclosporine in the treatment of chronic dry eye","volume":"6","author":"Schultz","year":"2014","journal-title":"Ophthalmol. Eye Dis."},{"key":"2025030702134073700_r67","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1126\/science.6367043","article-title":"Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset","volume":"223","author":"Stiller","year":"1984","journal-title":"Science"},{"key":"2025030702134073700_r68","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1056\/NEJM198803173181103","article-title":"Factors associated with early remission of type I diabetes in children treated with cyclosporine","volume":"318","author":"Bougneres","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"2025030702134073700_r69","doi-asserted-by":"crossref","first-page":"7165","DOI":"10.4049\/jimmunol.166.12.7165","article-title":"Sanglifehrin A, a novel cyclophilin-binding compound showing immunosuppressive activity with a new mechanism of action","volume":"166","author":"Zenke","year":"2001","journal-title":"J. Immunol."},{"key":"2025030702134073700_r70","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/clinchem\/45.9.1477","article-title":"Inhibition of stimulated interleukin-2 production in whole blood: a practical measure of cyclosporine effect","volume":"45","author":"Stein","year":"1999","journal-title":"Clin. Chem."},{"key":"2025030702134073700_r71","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1006\/clin.1996.0140","article-title":"The mechanism of action of cyclosporin A and FK506","volume":"80","author":"Ho","year":"1996","journal-title":"Clin. Immunol. Immunopathol."},{"key":"2025030702134073700_r72","doi-asserted-by":"crossref","first-page":"12037","DOI":"10.1073\/pnas.192206699","article-title":"Crystal structure of calcineurin-cyclophilin-cyclosporin shows common but distinct recognition of immunophilin-drug complexes","volume":"99","author":"Huai","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025030702134073700_r73","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1093\/ndt\/15.12.1916","article-title":"Clinical and mechanistic differences between FK506 (tacrolimus) and cyclosporin A","volume":"15","author":"Almawi","year":"2000","journal-title":"Nephrol. Dial. Transplant."},{"key":"2025030702134073700_r74","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.4049\/jimmunol.169.7.3555","article-title":"Contrasting impacts of immunosuppressive agents (rapamycin, FK506, cyclosporin A, and dexamethasone) on bidirectional dendritic cell-T cell interaction during antigen presentation","volume":"169","author":"Hiroyuki","year":"2002","journal-title":"J. Immunol."},{"key":"2025030702134073700_r75","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1097\/01.TP.0000153505.73700.32","article-title":"Inhibitory and stimulatory effects of cyclosporine A on the development of regulatory T cells in vivo","volume":"79","author":"Kawai","year":"2005","journal-title":"Transplantation"},{"key":"2025030702134073700_r76","doi-asserted-by":"crossref","first-page":"237","DOI":"10.4049\/jimmunol.0804028","article-title":"Type V collagen-induced oral tolerance plus low-dose cyclosporine prevents rejection of MHC class I and II incompatible lung allografts","volume":"183","author":"Yamada","year":"2009","journal-title":"J. Immunol."},{"key":"2025030702134073700_r77","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.2215\/CJN.03180509","article-title":"Immunosuppressive drugs and Tregs: a critical evaluation!","volume":"4","author":"De Serres","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"2025030702134073700_r78","doi-asserted-by":"crossref","first-page":"5172","DOI":"10.4049\/jimmunol.180.8.5172","article-title":"Cutting edge: immunosuppressant as adjuvant for tolerogenic immunization","volume":"180","author":"Kang","year":"2008","journal-title":"J. Immunol."},{"key":"2025030702134073700_r79","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/eji.201242468","article-title":"Dexamethasone promotes tolerance in vivo by enriching CD11cloCD40lo tolerogenic macrophages","volume":"43","author":"Zheng","year":"2013","journal-title":"Eur. J. Immunol."},{"key":"2025030702134073700_r80","doi-asserted-by":"crossref","first-page":"6211","DOI":"10.1016\/j.vaccine.2007.05.068","article-title":"Immunogenicity and efficacy of recombinant RSV-F vaccine in a mouse model","volume":"25","author":"Singh","year":"2007","journal-title":"Vaccine"},{"key":"2025030702134073700_r81","first-page":"493","article-title":"A simple method of estimating fifty percent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Hyg."},{"key":"2025030702134073700_r82","doi-asserted-by":"crossref","first-page":"5996","DOI":"10.1158\/0008-5472.CAN-08-4619","article-title":"Breast cancer lung metastasis requires expression of chemokine receptor CCR4 and regulatory T cells","volume":"69","author":"Olkhanud","year":"2009","journal-title":"Cancer Res."},{"key":"2025030702134073700_r83","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/CJI.0b013e318294357c","article-title":"Inhibition of lung metastasis by chemokine CCL17-mediated in vivo silencing of genes in CCR4+ Tregs","volume":"36","author":"Biragyn","year":"2013","journal-title":"J. Immunother."},{"key":"2025030702134073700_r84","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.imlet.2014.09.006","article-title":"Respiratory syncytial virus: pathology, therapeutic drugs and prophylaxis","volume":"162","author":"Gomez","year":"2014","journal-title":"Immunol. Lett."},{"key":"2025030702134073700_r85","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1128\/JVI.00036-09","article-title":"Regulatory T cells promote early influx of CD8+ T cells in the lungs of respiratory syncytial virus-infected mice and diminish immunodominance disparities","volume":"83","author":"Ruckwardt","year":"2009","journal-title":"J. Virol."},{"key":"2025030702134073700_r86","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.4049\/jimmunol.178.3.1433","article-title":"Naturally occurring lung CD4+CD25+ T cell regulation of airway allergic responses depends on IL-10 induction of TGF-\u03b2","volume":"178","author":"Joetham","year":"2007","journal-title":"J. Immunol."},{"key":"2025030702134073700_r87","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/ndt\/gfp586","article-title":"Rapamycin, unlike cyclosporine A, enhances suppressive functions of in vitro-induced CD4+CD25+ Tregs","volume":"25","author":"Bocian","year":"2010","journal-title":"Nephrol. Dial. Transplant."},{"key":"2025030702134073700_r88","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1016\/j.transproceed.2009.08.043","article-title":"Inhibitory effects of cyclosporine on human regulatory T cells in vitro","volume":"41","author":"Miroux","year":"2009","journal-title":"Transplant. Proc."},{"key":"2025030702134073700_r89","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1007\/s00417-010-1420-z","article-title":"Influence of combined treatment of low dose rapamycin and cyclosporin A on corneal allograft survival","volume":"248","author":"Stanojlovic","year":"2010","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"2025030702134073700_r90","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1111\/j.1398-9995.2009.02054.x","article-title":"Low-dose cyclosporine A therapy increases the regulatory T cell population in patients with atopic dermatitis","volume":"64","author":"Brandt","year":"2009","journal-title":"Allergy"},{"key":"2025030702134073700_r91","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/j.intimp.2006.07.019","article-title":"Peripheral CD4+ CD25+ Treg cell expansion in lung transplant recipients is not affected by calcineurin inhibitors","volume":"6","author":"Meloni","year":"2006","journal-title":"Int. Immunopharmacol."},{"key":"2025030702134073700_r92","doi-asserted-by":"crossref","first-page":"9231","DOI":"10.1073\/pnas.87.23.9231","article-title":"Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin","volume":"87","author":"Bierer","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025030702134073700_r93","doi-asserted-by":"crossref","first-page":"4517","DOI":"10.1182\/blood-2001-11-0062","article-title":"Effect of rapamycin on the cyclosporin A-resistant CD28-mediated costimulatory pathway","volume":"99","author":"Ghosh","year":"2002","journal-title":"Blood"},{"key":"2025030702134073700_r94","doi-asserted-by":"publisher","first-page":"pii: e13008","DOI":"10.1371\/journal.pone.0013008","article-title":"Cyclosporine A-sensitive, cyclophilin B-dependent endoplasmic reticulum-associated degradation","volume":"5","author":"Riccardo","year":"2010","journal-title":"PLoS One"},{"key":"2025030702134073700_r95","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10495-012-0778-2","article-title":"Synergistic Bcl-2 inhibition by ABT-737 and cyclosporine A","volume":"18","author":"Cipp\u00e0","year":"2013","journal-title":"Apoptosis"},{"key":"2025030702134073700_r96","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1097\/TP.0b013e3181874a36","article-title":"Effects of immunosuppressive drugs on purified human B cells: evidence supporting the use of MMF and rapamycin","volume":"86","author":"Heidt","year":"2008","journal-title":"Transplantation"},{"key":"2025030702134073700_r97","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1097\/00007890-200206150-00019","article-title":"Tacrolimus and cyclosporine differ in their capacity to overcome ongoing allograft rejection as a result of their differential abilities to inhibit interleukin-10 production","volume":"73","author":"Jiang","year":"2002","journal-title":"Transplantation"},{"key":"2025030702134073700_r98","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1084\/jem.188.7.1297","article-title":"Different protein tyrosine kinases are required for B cell antigen receptor-mediated activation of extracellular signal-regulated kinase, c-Jun NH2-terminal kinase 1, and p38 mitogen-activated protein kinase","volume":"188","author":"Jiang","year":"1998","journal-title":"J. Exp. Med."},{"key":"2025030702134073700_r99","doi-asserted-by":"crossref","first-page":"6030","DOI":"10.4049\/jimmunol.174.10.6030","article-title":"Cyclophilin A-deficient mice are resistant to immunosuppression by cyclosporine","volume":"174","author":"John","year":"2005","journal-title":"J. Immunol."},{"key":"2025030702134073700_r100","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1093\/embo-reports\/kvd090","article-title":"Two distinct action mechanisms of immunophilin-ligand complexes for the blockade of T-cell activation","volume":"1","author":"Matsuda","year":"2000","journal-title":"EMBO Rep."},{"key":"2025030702134073700_r101","doi-asserted-by":"crossref","first-page":"10468","DOI":"10.1073\/pnas.1201131109","article-title":"Regulatory T cells use programmed death 1 ligands to directly suppress autoreactive B cells in vivo","volume":"109","author":"Gotot","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025030702134073700_r102","first-page":"2668","article-title":"Regulatory T cells and B cells: implication on autoimmune diseases","volume":"6","author":"Wang","year":"2013","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"2025030702134073700_r103","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1182\/blood-2005-11-4502","article-title":"Activated CD4+CD25+ T cells selectively kill B lymphocytes","volume":"107","author":"Zhao","year":"2006","journal-title":"Blood"},{"key":"2025030702134073700_r104","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1002\/eji.200939392","article-title":"CD46-induced human Treg enhance B-cell responses","volume":"39","author":"Fuchs","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"2025030702134073700_r105","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1136\/annrheumdis-2013-204049","article-title":"B cell resistance to Fas-mediated apoptosis contributes to their ineffective control by regulatory T cells in rheumatoid arthritis","volume":"74","author":"Rapetti","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"2025030702134073700_r106","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00262-012-1313-6","article-title":"B lymphocyte inhibition of anti-tumor response depends on expansion of Treg but is independent of B-cell IL-10 secretion","volume":"62","author":"Zhang","year":"2013","journal-title":"Cancer Immunol. Immunother."},{"key":"2025030702134073700_r107","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1172\/JCI116977","article-title":"Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein","volume":"93","author":"Levy","year":"1994","journal-title":"J. Clin. Invest."},{"key":"2025030702134073700_r108","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1084\/jem.181.3.839","article-title":"Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus","volume":"181","author":"Llorente","year":"1995","journal-title":"J. Exp. Med."},{"key":"2025030702134073700_r109","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1093\/intimm\/7.8.1243","article-title":"Long-term cultured CD40-activated B lymphocytes differentiate into plasma cells in response to IL-10 but not IL-4","volume":"7","author":"Rousset","year":"1995","journal-title":"Int. Immunol."},{"key":"2025030702134073700_r110","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1189\/jlb.0409268","article-title":"IL-21 and IL-10 have redundant roles but differential capacities at different stages of plasma cell generation from human germinal center B cells","volume":"86","author":"Yoon","year":"2009","journal-title":"J. Leukoc. Biol."},{"key":"2025030702134073700_r111","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.4049\/jimmunol.150.9.3671","article-title":"Human B cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokines","volume":"150","author":"Armitage","year":"1993","journal-title":"J. Immunol."},{"key":"2025030702134073700_r112","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3389\/fimmu.2014.00065","article-title":"Cytokine-mediated regulation of plasma cell generation: IL-21 takes center stage","volume":"5","author":"Moens","year":"2014","journal-title":"Front. Immunol."},{"key":"2025030702134073700_r113","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2217\/fmb.10.22","article-title":"Prospects for defined epitope vaccines for respiratory syncytial virus","volume":"5","author":"Anderson","year":"2010","journal-title":"Future Microbiol."},{"key":"2025030702134073700_r114","doi-asserted-by":"crossref","first-page":"10569","DOI":"10.1128\/JVI.01503-14","article-title":"Prophylaxis with a respiratory syncytial virus (RSV) anti-G protein monoclonal antibody shifts the adaptive immune response to RSV rA2-line19F infection from Th2 to Th1 in BALB\/c mice","volume":"88","author":"Boyoglu-Barnum","year":"2014","journal-title":"J. Virol."},{"key":"2025030702134073700_r115","first-page":"14","article-title":"Effect of chemokine receptor CX3CR1 deficiency in a murine model of respiratory syncytial virus infection","volume":"62","author":"Johnson","year":"2012","journal-title":"Comp. Med."},{"key":"2025030702134073700_r116","doi-asserted-by":"crossref","first-page":"6580","DOI":"10.1128\/JVI.77.11.6580-6584.2003","article-title":"The G glycoprotein of respiratory syncytial virus depresses respiratory rates through the CX3C motif and substance P","volume":"77","author":"Tripp","year":"2003","journal-title":"J. Virol."}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/196\/4\/1721\/62255275\/1502103.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/196\/4\/1721\/62255275\/1502103.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T02:24:08Z","timestamp":1741314248000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/196\/4\/1721\/7961868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":116,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,2,15]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.1502103","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,2]]},"published":{"date-parts":[[2016,2]]}}}